Zymeworks Newsroom

Zymeworks Analyst Ratings

BenzingaNov 22 06:55 ET

Zymeworks Hold Rating: Balancing FDA Milestones With Market Valuation and Future Risks

TipRanksNov 22 06:27 ET

Leerink Partners Maintains Zymeworks(ZYME.US) With Buy Rating, Raises Target Price to $26

Moomoo NewsNov 21 16:31 ET

Zymeworks Analyst Ratings

BenzingaNov 7 07:17 ET

Leerink Partners Upgrades Zymeworks(ZYME.US) to Buy Rating, Raises Target Price to $25

Moomoo NewsNov 7 06:31 ET

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsNov 1 08:31 ET

Zymeworks Analyst Ratings

BenzingaNov 1 07:24 ET

Zymeworks Analyst Ratings

BenzingaOct 28 09:54 ET

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Raises Target Price to $28

Moomoo NewsOct 28 08:34 ET

Maintaining Neutral: Hold Rating on Zymeworks Amidst Preclinical Progress and Upcoming Catalysts

TipRanksSep 25 06:17 ET

Zymeworks Analyst Ratings

BenzingaSep 18 07:07 ET

Zymeworks' Hold Rating Amidst Promising Data and Competitive HER2+ GEA Treatment Landscape

TipRanksSep 18 06:29 ET

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsSep 10 08:31 ET

Stifel Nicolaus Keeps Their Buy Rating on Zymeworks (ZYME)

TipRanksSep 10 07:40 ET

Buy Rating on Zymeworks Stock Amid Anticipated Zani Approval and Strategic Capital Allocation

TipRanksAug 12 06:44 ET

Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC), Zymeworks (ZYME) and Rocket Pharmaceuticals (RCKT)

TipRanksAug 7 01:34 ET

Zymeworks Analyst Ratings

BenzingaAug 2 14:01 ET

Zymeworks (ZYME) Receives a Buy From Stifel Nicolaus

TipRanksAug 2 08:56 ET

Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Raises Target Price to $21

Moomoo NewsAug 2 08:35 ET

Maintaining Hold on Zymeworks: A Balanced View of Financials and Future Catalysts

TipRanksAug 2 06:27 ET